Literature DB >> 16002205

Glucose-induced lipogenesis in pancreatic beta-cells is dependent on SREBP-1.

Maria B Sandberg1, Jakob Fridriksson, Lise Madsen, Vikas Rishi, Charles Vinson, Holm Holmsen, Rolf K Berge, Susanne Mandrup.   

Abstract

High concentrations of glucose induce de novo fatty acid synthesis in pancreatic beta-cells and chronic exposure of elevated glucose and fatty acids synergize to induce accumulation of triglycerides, a phenomenon termed glucolipotoxicity. Here we investigate the role of sterol-regulatory element binding proteins in glucose-induced lipogenesis in the pancreatic beta-cell line INS-1E. We show that glucose induces SREBP-1c expression and SREBP-1 activity independent of insulin secretion and signaling. Using adenoviral expression of SREBP-1c and a SREBP-mutant we show that lipogenic gene expression, de novo fatty acid synthesis and lipid accumulation are induced primarily through sterol-regulatory elements (SREs) and not E-Boxes. Adenoviral expression of a dominant negative SREBP compromises glucose induction of some lipogenic genes and significantly reduces glucose-induction of de novo fatty acid synthesis. Thus, we demonstrate for the first time that SREBP activity is necessary for full glucose induction of de novo fatty acid synthesis in pancreatic beta-cells.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16002205     DOI: 10.1016/j.mce.2005.05.005

Source DB:  PubMed          Journal:  Mol Cell Endocrinol        ISSN: 0303-7207            Impact factor:   4.102


  8 in total

1.  Nutrigenomics, beta-cell function and type 2 diabetes.

Authors:  R Nino-Fong; Tm Collins; Cb Chan
Journal:  Curr Genomics       Date:  2007-03       Impact factor: 2.236

2.  Metabolic fate of glucose and candidate signaling and excess-fuel detoxification pathways in pancreatic β-cells.

Authors:  Yves Mugabo; Shangang Zhao; Julien Lamontagne; Anfal Al-Mass; Marie-Line Peyot; Barbara E Corkey; Erik Joly; S R Murthy Madiraju; Marc Prentki
Journal:  J Biol Chem       Date:  2017-03-09       Impact factor: 5.157

3.  Glucolipotoxicity promotes the capacity of the glycerolipid/NEFA cycle supporting the secretory response of pancreatic beta cells.

Authors:  Lucie Oberhauser; Cecilia Jiménez-Sánchez; Jesper Grud Skat Madsen; Dominique Duhamel; Susanne Mandrup; Thierry Brun; Pierre Maechler
Journal:  Diabetologia       Date:  2022-01-12       Impact factor: 10.122

4.  Role of NMDA receptor-dependent activation of SREBP1 in excitotoxic and ischemic neuronal injuries.

Authors:  Changiz Taghibiglou; Henry G S Martin; Ted Weita Lai; Taesup Cho; Shiv Prasad; Luba Kojic; Jie Lu; Yitao Liu; Edmund Lo; Shu Zhang; Julia Z Z Wu; Yu Ping Li; Yan Hua Wen; Joon-Hyuk Imm; Max S Cynader; Yu Tian Wang
Journal:  Nat Med       Date:  2009-11-22       Impact factor: 53.440

5.  Overexpression of Insig-1 protects β cell against glucolipotoxicity via SREBP-1c.

Authors:  Ke Chen; Ping Jin; Hong-hui He; Yan-hong Xie; Xiao-yun Xie; Zhao-hui Mo
Journal:  J Biomed Sci       Date:  2011-08-16       Impact factor: 8.410

Review 6.  Lipid-Induced Adaptations of the Pancreatic Beta-Cell to Glucotoxic Conditions Sustain Insulin Secretion.

Authors:  Lucie Oberhauser; Pierre Maechler
Journal:  Int J Mol Sci       Date:  2021-12-28       Impact factor: 5.923

7.  Elevated insulin secretion from liver X receptor-activated pancreatic beta-cells involves increased de novo lipid synthesis and triacylglyceride turnover.

Authors:  Christopher D Green; Donald B Jump; L Karl Olson
Journal:  Endocrinology       Date:  2009-02-19       Impact factor: 4.736

8.  Elk1 and SRF transcription factors convey basal transcription and mediate glucose response via their binding sites in the human LXRB gene promoter.

Authors:  Maria Nilsson; Karin Dahlman-Wright; Charlotta Karelmo; Martin Ebeling; Jan-Ake Gustafsson; Knut R Steffensen
Journal:  Nucleic Acids Res       Date:  2007-07-10       Impact factor: 16.971

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.